English

#ESMO22 Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HD

Published 2022-09-13

Download video

Download video MP4 360p

Recommendations

03:30

ESMO Course in medical oncology for medical students: why should you apply?
01:52

Side Effects of Oxaliplatin
57:38

ESMO Patient Guides: Let's talk about oesophageal and stomach cancers
04:57

Precision Medicine in Carcinoma of Unknown Primary with Alwin Krämer
08:44

THIS guy solved Panic Attacks after 30 years of Panic Disorder
22:49

Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD
07:56

WHO-ESMO Collaboration Plan 2024-2026
02:56

#ESMO22 Highlights on cabozantinib with nivo and ipi for intermediate/poor risk adv. RCC: COSMIC-313
01:08

ESMO Sarcoma and Rare Cancers 2024: Why young oncologists should attend
01:52

ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat
01:19

ESMO Gastrointestinal Cancers Congress 2024: What To Expect
01:58

ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend
01:35

ESMO Gastrointestinal Cancers Congress 2024: Why You Should Attend
01:48

#ELCC24: Reasons Why You Should Attend
01:46

#ESMOBreast24: Reasons to attend this top, international Congress for the breast cancer community
01:34

ESMO Sarcoma and Rare Cancers 2024: Reasons To Attend
03:39

Highlights from the ESMO Patient Guides event ‘Let's talk about oesophageal and stomach cancers’
01:51

#ESMOBreast24: International breast cancer experts invite you to attend
01:59

ESMO Gastrointestinal Cancers Congress 2024: Reasons To Attend

Similar videos

28:31

Prostate Cancer Highlights from ESMO 2022
01:19

Highlights in prostate cancer from ESMO
03:35

#ESMO22 Highlights on the efficacy and safety of fruquintinib in refractory mCRC: The FRESCO-2 study
02:30

#ESMO22 Highlights on first-line atezolizumab in NSCLC not eligible for platinum: The IPSOS study
02:05

STARTAR: ADT with apalutamide, radiation therapy and docetaxel in prostate cancer
16:33

Genitourinary Cancer ESMO 2022 Highlights - OncBrothers (Rohit & Rahul Gosain) w/ Dr. Toni Choueiri
01:17

When is ADT Used in Men Who Choose Prostatectomy?
06:41

ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022
01:27

Genitourinary cancer highlights at ESMO 2022
06:25

Practice-changing data from ESMO 2021 in prostate cancer
02:58

#ESMO22 Highlights on sacituzumab govitecan in HR+/HER2- metastatic breast cancer: TROPiCS-02
00:52

Clinical trial updates in prostate cancer at ESMO 2022
11:48

Localized Prostate Cancer: Androgen Deprivation Therapy (ADT) - 2021 Prostate Cancer Conference
08:59

Role of ADT with Radiation
03:41

SWOG S1216: ADT and TAK700 in prostate cancer
09:48

PCa Commentary September 2022: ADT & Radiotherapy
00:47

Systemic triple therapy in metastatic hormone-sensitive prostate cancer
1:00:27

Webinar: Predicting Benefit of ADT with RT in Prostate Cancer